特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
933870

心臓バイオマーカー診断キットの世界市場:製品タイプ・適応症・地域別の市場規模と予測

Global Cardiac Biomarker Diagnostic Kits Market Size study, by Product Type, by Disease Indication by End User and Regional Forecasts 2020-2026

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.40円
心臓バイオマーカー診断キットの世界市場:製品タイプ・適応症・地域別の市場規模と予測
出版日: 2020年04月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心臓バイオマーカー診断キットの市場規模は、2019年に23億3,000万米ドルと評価され、2019年から2026年にかけては5.4%を超えるCAGRで推移すると予測されています。心臓バイオマーカー診断キットには、心臓の機能を測定・評価する際に使用される器具や機器で構成され、心臓関連疾患の早期予測や診断に活用されています。心血管疾患の有病率の世界的な上昇が当市場の主な成長要因となっています。

当レポートでは、世界の心臓バイオマーカー診断キット市場を調査し、市場の概要、製品タイプ・適応症・地域別の市場規模の推移と予測、市場の成長要因および課題の分析、市場機会、地域・国別の詳細動向、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 エグゼクティブサマリー

  • 市場のスナップショット
  • 市場規模の推移と予測:全体・セグメント別
    • 地域別
    • 製品タイプ別
    • 適応症
    • エンドユーザー別
  • 主要動向
  • 予測手法
  • 調査の前提条件

第2章 市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査範囲
    • 業界の発展
  • 調査対象期間
  • 通貨換算レート

第3章 市場力学

  • 市場影響要因の分析
    • 市場の成長要因
    • 市場の課題
    • 市場機会

第4章 心臓バイオマーカー診断キット市場:業界分析

  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ファイブフォースモデルへの未来的なアプローチ
  • PEST分析
  • 投資採用モデル
  • アナリストの提言と結論

第5章 心臓バイオマーカー診断キット市場:製品タイプ別

  • 市場のスナップショット
  • 市場パフォーマンス - 潜在性の分析:製品タイプ別
  • 市場規模:製品タイプ別(実績値・予測値)
  • 市場分析:製品タイプ別
    • 試薬・キット
    • 機器
    • 化学発光
    • ELISA
    • 免疫蛍光染色
    • 免疫クロマトグラフィー

第6章 心臓バイオマーカー診断キット市場:適応症別

  • 市場のスナップショット
  • 市場パフォーマンス - 潜在性の分析:適応症別
  • 市場規模:適応症別(実績値・予測値)
  • 市場分析:適応症別
    • 狭心症
    • 心筋梗塞
    • 心不全
    • その他

第7章 心臓バイオマーカー診断キット市場:エンドユーザー別

  • 市場のスナップショット
  • 市場パフォーマンス - 潜在性の分析:エンドユーザー別
  • 市場規模:エンドユーザー別(実績値・予測値)
  • 市場分析:エンドユーザー別
    • 病院
    • 診断センター
    • 診療所
    • その他

第8章 心臓バイオマーカー診断キット市場:地域別

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Roche Diagnostics Limited
    • Abbott Laboratories
    • Siemens AG
    • Danaher Corporation
    • Biomerieux SA
    • Alere Inc.
    • LSI Medience Corporation
    • Ortho Clinical Diagnostics
    • Randox Laboratories Ltd.
    • Guangzhou Wondfo Biotech Co., Ltd.

第10章 調査方法

図表

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET
  • TABLE 3. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY DISEASES INDICATION 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. U.S. CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. U.S. CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 23. CANADA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. CANADA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. CANADA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 26. UK CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. UK CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. UK CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 32. ROE CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. ROE CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. ROE CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35. CHINA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. CHINA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. CHINA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38. INDIA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. INDIA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. INDIA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. ROAPAC CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. ROLA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 54. ROLA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROLA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. ROW CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. ROW CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. ROW CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

List of Figures

  • FIG 1. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, GROWTH PROSPECTS 2020-2026
  • FIG 6. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KIT MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
目次

Global Cardiac Biomarker Diagnostic Kits Market is valued approximately USD 2.33 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.4% over the forecast period 2019-2026. Cardiac Biomarker diagnostic kits is a subset of tools and instruments those are used to measure and evaluate heart functions. It has remarkable role in early prediction or diagnosis of heart related diseases. It has favorable benefits in early prediction of heart diseases and has capable of evaluating significant cure or treatment of cardiovascular diseases. Therefore, increasing prevalence of cardiovascular diseases across the globe is the factor attributed to drive the growth of market over the forecast years. For instance: As per the World Health Organization, Cardiovascular diseases are estimated as the primary reason of death due to disease across the globe which accounts for over 17.9 million, 31% of worldwide death each year due to cardiovascular disease. It is estimated that more than 75% of deaths occurred through cardiovascular disease is emerged in low and middle-income countries and over 85% of deaths are taking place due to sever heart attacks and strokes. In Addition, increasing geriatric population across the globe in emerging economies is expected to fuel the lucrative thrust to the growth of market over the upcoming year 2020-2026. However, high cost of cardiac biomarker diagnostic kits in emerging economies would expect to hamper the growth of market over the forthcoming period.

The regional analysis of global Cardiac Biomarker Diagnostic Kits market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growth in disposable income of the population along with increasing investment in healthcare sector in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rapid growth in cardiovascular diseases and ageing population in the region would create lucrative growth prospects for the Cardiac Biomarker Diagnostic Kits market across Asia-Pacific region.

Major market player included in this report are:

Roche Diagnostics Limited

Abbott Laboratories

Siemens AG

Danaher Corporation

Biomerieux SA

Alere Inc.

LSI Medience Corporation

Ortho Clinical Diagnostics

Randox Laboratories Ltd.

Guangzhou Wondfo Biotech Co., Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Reagents and Kits

Instruments

Chemiluminescence

Immunofluorescence

Elisa

Immunochromatography

By Disease Indication:

Angina Pectoris

Myocardial Infraction

Cardiac Heart Failure

Others

By End-User:

Hospitals

Diagnostic Centers

Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 20198

Forecast period - 2020 to 2026

Target Audience of the Global Cardiac Biomarker Diagnostic Kits Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1. Cardiac Biomarker Diagnostic Kit Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2. Cardiac Biomarker Diagnostic Kit Market, by Product Type, 2018-2026 (USD Billion)
    • 1.2.3. Cardiac Biomarker Diagnostic Kit Market, by Diseases Indication, 2018-2026 (USD Billion)
    • 1.2.4. Cardiac Biomarker Diagnostic Kit Market, by End-User, 2018-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cardiac Biomarker Diagnostic Kit Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cardiac Biomarker Diagnostic Kit Market Dynamics

  • 3.1. Cardiac Biomarker Diagnostic Kit Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Cardiac Biomarker Diagnostic Kit Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cardiac Biomarker Diagnostic Kit Market, by Product Type

  • 5.1. Market Snapshot
  • 5.2. Global Cardiac Biomarker Diagnostic Kit Market by Product Type, Performance - Potential Analysis
  • 5.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by Product Type 2016-2026 (USD Billion)
  • 5.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
    • 5.4.1. Reagents and Kits
    • 5.4.2. Instruments
    • 5.4.3. Chemiluminescence
    • 5.4.4. Immunofluorescence
    • 5.4.5. Elisa
    • 5.4.6. Immunochromatography

Chapter 6. Global Cardiac Biomarker Diagnostic Kit Market, by Diseases Indication

  • 6.1. Market Snapshot
  • 6.2. Global Cardiac Biomarker Diagnostic Kit Market by Diseases Indication, Performance - Potential Analysis
  • 6.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by Diseases Indication 2016-2026 (USD Billion)
  • 6.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
    • 6.4.1. Angina Pectoris
    • 6.4.2. Myocardial Infraction
    • 6.4.3. Cardiac Heart Failure
    • 6.4.4. Others

Chapter 7. Global Cardiac Biomarker Diagnostic Kit Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Cardiac Biomarker Diagnostic Kit Market by End-User, Performance - Potential Analysis
  • 7.3. Global Cardiac Biomarker Diagnostic Kit Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
  • 7.4. Cardiac Biomarker Diagnostic Kit Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Diagnostic Centres
    • 7.4.3. Clinics
    • 7.4.4. Others

Chapter 8. Global Cardiac Biomarker Diagnostic Kit Market, Regional Analysis

  • 8.1. Cardiac Biomarker Diagnostic Kit Market, Regional Market Snapshot
  • 8.2. North America Cardiac Biomarker Diagnostic Kit Market
    • 8.2.1. U.S. Cardiac Biomarker Diagnostic Kit Market
      • 8.2.1.1. Product Type breakdown estimates & forecasts, 2016-2026
      • 8.2.1.2. Diseases Indication breakdown estimates & forecasts, 2016-2026
      • 8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026
    • 8.2.2. Canada Cardiac Biomarker Diagnostic Kit Market
  • 8.3. Europe Cardiac Biomarker Diagnostic Kit Market Snapshot
    • 8.3.1. U.K. Cardiac Biomarker Diagnostic Kit Market
    • 8.3.2. Germany Cardiac Biomarker Diagnostic Kit Market
    • 8.3.3. Rest of Europe Cardiac Biomarker Diagnostic Kit Market
  • 8.4. Asia-Pacific Cardiac Biomarker Diagnostic Kit Market Snapshot
    • 8.4.1. China Cardiac Biomarker Diagnostic Kit Market
    • 8.4.2. India Cardiac Biomarker Diagnostic Kit Market
    • 8.4.3. Japan Cardiac Biomarker Diagnostic Kit Market
    • 8.4.4. Rest of Asia Pacific Cardiac Biomarker Diagnostic Kit Market
  • 8.5. Latin America Cardiac Biomarker Diagnostic Kit Market Snapshot
    • 8.5.1. Brazil Cardiac Biomarker Diagnostic Kit Market
    • 8.5.2. Mexico Cardiac Biomarker Diagnostic Kit Market
  • 8.6. Rest of The World Cardiac Biomarker Diagnostic Kit Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Roche Diagnostics Limited
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Abbott Laboratories
    • 9.2.3. Siemens AG
    • 9.2.4. Danaher Corporation
    • 9.2.5. Biomerieux SA
    • 9.2.6. Alere Inc.
    • 9.2.7. LSI Medience Corporation
    • 9.2.8. Ortho Clinical Diagnostics
    • 9.2.9. Randox Laboratories Ltd.
    • 9.2.10. Guangzhou Wondfo Biotech Co., Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.